Funder
COPD Foundation
Novartis Pharmaceuticals Corporation
National Institutes of Health
GlaxoSmithKline
Subject
Pulmonary and Respiratory Medicine
Reference22 articles.
1. The state of US health, 1990-2016: burden of diseases, injuries, and risk factors among US States;Collaborators;JAMA,2018
2. Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD;Rabe;N. Engl. J. Med.,2020
3. The effect of inhaled corticosteroid withdrawal and baseline inhaled treatment on exacerbations in the impact study. A randomized, double-blind, multicenter clinical trial;Han;Am. J. Respir. Crit. Care Med.,2020
4. Idiopathic pulmonary fibrosis: current and future treatment;Glass;Clin. Res. J,2022
5. Underlying and immediate causes of death in patients with idiopathic pulmonary fibrosis;Karkkainen;BMC Pulm. Med.,2018
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献